While anti-inflammatory cytokines within this group, such as IFNα/β, IL-10, IL-11 and IL-22, were shown to be beneficial in animal models of IBD, their administration did not show any significant beneficial effects in patients with IBD [119,120,121,122,123,124,125,126]. Here, IL10 is linked to inflammatory bowel disease.